Chronic lymphocytic leukemia clinical staging: Difference between revisions
No edit summary |
|||
Line 11: | Line 11: | ||
|valign=top| | |valign=top| | ||
|+ | |+ | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Stage}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Stage'''}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Hemoglobin Level}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Hemoglobin Level'''}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Platelets Level}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Platelets Level'''}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Lymphocytosis}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Lymphocytosis'''}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Splenomegaly}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Splenomegaly'''}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Lymphadenopathy}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Lymphadenopathy'''}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Median Survival}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Median Survival'''}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
Stage 0 | '''Stage 0''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
>11 g/dL | >11 g/dL | ||
Line 39: | Line 39: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
Stage 1 | '''Stage 1''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
>11 g/dL | >11 g/dL | ||
Line 56: | Line 56: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
Stage 2 | '''Stage 2''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
>11 g/dL | >11 g/dL | ||
Line 73: | Line 73: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
Stage 3 | '''Stage 3''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
<11 g/dL | <11 g/dL | ||
Line 90: | Line 90: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
Stage 4 | '''Stage 4''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
<11 g/dL or >11g/dL | <11 g/dL or >11g/dL | ||
Line 104: | Line 104: | ||
19 months | 19 months | ||
|} | |} | ||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 18:46, 14 October 2015
Chronic lymphocytic leukemia Microchapters |
Differentiating Chronic lymphocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Chronic lymphocytic leukemia clinical staging On the Web |
American Roentgen Ray Society Images of Chronic lymphocytic leukemia clinical staging |
Directions to Hospitals Treating Chronic lymphocytic leukemia |
Risk calculators and risk factors for Chronic lymphocytic leukemia clinical staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Staging System
Rai Staging System
According to the Rai Staging System, there are five stages of chronic lymphocytic leukemia based on the degree of lymphocytosis, hemoglobin level, platelets level, the presence of splenomegaly, and the presence of lymphadenopathy.[1]
Stage | Hemoglobin Level | Platelets Level | Lymphocytosis | Splenomegaly | Lymphadenopathy | Median Survival |
---|---|---|---|---|---|---|
Stage 0 |
>11 g/dL |
>100,000/L |
Present |
Absent |
Absent |
>150 months |
Stage 1 |
>11 g/dL |
>100,000/L |
Present |
Absent |
Present |
101 months |
Stage 2 |
>11 g/dL |
>100,000/L |
Present |
Present |
Present or absent |
71 months |
Stage 3 |
<11 g/dL |
>100,000/L |
Present |
Present or absent |
Present or absent |
19 months |
Stage 4 |
<11 g/dL or >11g/dL |
<100,000/L |
Present |
Present or absent |
Present or absent |
19 months |
References
- ↑ Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975). "Clinical staging of chronic lymphocytic leukemia". Blood. 46 (2): 219–34. PMID 1139039.